Home
§ INFEX
   Adeno/Rota
   Brucella/Burkholderia
   Campylo./Pylori
   E.Coli/Neisseria
   Fungi/Mycoplasma
   Hepatitis
Antibodies
Antigens
Kits
Genotyping
Hepatitis A
Hepatitis E
Rapid Tests
Whole Genome
QC
QC-HAV IgM
QC-HAV RNA
QC-HBc IgM
QC-HBV_MYDD
QC-HEV IgG
QC-HEV IgM
QC-HGV
LT-HAV
LT-HBV
LT-HEV
Vaccine
   Herpes
   Influ
   Legionellosis
   Parasite
   Q-Fever
   Respiratory
   TB/Typhoid
   Vector-Borne
§ BIOMARKERS
   Alzheimer
Autoantigens
   Cancer
   Coronary Heat
   Cyto-/Endocrine
   Diabetes
   Hematology
   HLA
   Hormones
   Rheumatitis
   Sepsis
§ REAGENTS
§ CONTACTS


 



HBV with YMDD Mutation: HBsAg Negativity 

  • Cat.No. HBV-MY001: Serum/Plasma
  • Cat.No.HBV-MY002: Cloned DNA


Certificate of Analysis:

1)      Introduction:                   

The major envelope protein of hepatitis B surface antigen (HBsAg) which consists of 226 amino acids is coded by the S gene. The common antigenic determinant epitopes of all subtypes of HBsAg are found in á´determinant which is between amino acids 124 to 147.  This important region is considered to be within a larger antigenic area called the major hydrophilic region (NHR), and targeted antibodies against these epitopes are used in standard assays for HBsAg to diagnose hepatitis B virus (HBV) infection.  However, HBsAg negative chronic hepatitis B (CHB) cases with a detectable level of HBV DNA by Polymerase chain reaction (PCR) are emerging. This is defined as occult HBV infection and has been reported in 9.4% of CHB patients. Various relevant mutations have been implicated in such HBsAg negativity.

2)      Source:                           

Human Plasma/Serum

3)      Markers:                       

HBsAg (-), Anti-HBs 3 mIU/ml), HBeAg(+), Anti-HBe(+), HBV DNA (29.3 pg/ml), ALT (130IU/L)

4)      Genotype:                                  

Genotype C and subtype adr

5)      Features:                        

Pre-S2 deletion mutant: The pre-S2 amplification products showed deletion from nucleotide 23 to 55. This finding was consistent with the deletion of amino acids 12 to 22 in the pre-S2 regions

Mutations on the á´determinant: PCR amplification and sequencing analyses revealed point mutations resulting in amino acid substitutions at the group á´determinant.

YMDD Mutation: A mutation in the YMDD (tyrosine, aspartate, aspartate) motif of the viral polymerise (reverse transcriptase) was noticed as methionine 204 to isoleucine (rtM204I)



Figure 1: Amino acid substitution within the á´ loop structure of HBsAg protein. Sequencing revealed substitutions at position I126S, T1311N, M133T and S136Y in the á´ determinant of the S gene. Black circles represent residues with mutations while gray circles represent cysteines. White circles represent other residues.


6) Volume:                            

  • 1ml/vial (Serum)
  • 0.01ml/vial (Cloned DNA)